TW228000B - - Google Patents

Info

Publication number
TW228000B
TW228000B TW082101659A TW82101659A TW228000B TW 228000 B TW228000 B TW 228000B TW 082101659 A TW082101659 A TW 082101659A TW 82101659 A TW82101659 A TW 82101659A TW 228000 B TW228000 B TW 228000B
Authority
TW
Taiwan
Application number
TW082101659A
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Application granted granted Critical
Publication of TW228000B publication Critical patent/TW228000B/zh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/64—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms, e.g. histidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
    • C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
TW082101659A 1992-04-01 1993-03-06 TW228000B (zh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4210787A DE4210787A1 (de) 1992-04-01 1992-04-01 Cycloalkyl- und Heterocyclyl substituierte Imidazolylpropensäurederivate

Publications (1)

Publication Number Publication Date
TW228000B true TW228000B (zh) 1994-08-11

Family

ID=6455696

Family Applications (1)

Application Number Title Priority Date Filing Date
TW082101659A TW228000B (zh) 1992-04-01 1993-03-06

Country Status (16)

Country Link
EP (1) EP0563705A2 (zh)
JP (1) JPH0625179A (zh)
KR (1) KR930021623A (zh)
CN (1) CN1077711A (zh)
AU (1) AU3562093A (zh)
CA (1) CA2092886A1 (zh)
CZ (1) CZ34993A3 (zh)
DE (1) DE4210787A1 (zh)
FI (1) FI931424A (zh)
HU (1) HUT64037A (zh)
IL (1) IL105189A0 (zh)
MX (1) MX9301651A (zh)
NO (1) NO930947L (zh)
SK (1) SK27593A3 (zh)
TW (1) TW228000B (zh)
ZA (1) ZA932301B (zh)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999007365A1 (en) * 1997-08-06 1999-02-18 Smithkline Beecham Corporation Eprosartan arginyl charge-neutralization-complex and a process for its production and formulation

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0403159T3 (da) * 1989-06-14 2000-08-14 Smithkline Beecham Corp Imidazolylalkensyrer
CA2018443A1 (en) * 1989-06-14 1990-12-14 Joseph A. Finkelstein Imidazolyl-alkenoic acids
CA2027937A1 (en) * 1989-10-25 1991-04-26 Richard M. Keenan Substituted 5-¬ (tetrazolyl)alkenyl|imidazoles

Also Published As

Publication number Publication date
KR930021623A (ko) 1993-11-22
FI931424A (fi) 1993-10-02
NO930947D0 (no) 1993-03-16
DE4210787A1 (de) 1993-10-07
CZ34993A3 (en) 1994-01-19
HU9300954D0 (en) 1993-06-28
CA2092886A1 (en) 1993-10-02
MX9301651A (es) 1993-10-01
FI931424A0 (fi) 1993-03-30
HUT64037A (en) 1993-11-29
CN1077711A (zh) 1993-10-27
NO930947L (no) 1993-10-04
AU3562093A (en) 1993-10-07
JPH0625179A (ja) 1994-02-01
ZA932301B (en) 1993-10-25
EP0563705A3 (zh) 1994-04-20
EP0563705A2 (de) 1993-10-06
IL105189A0 (en) 1993-07-08
SK27593A3 (en) 1994-04-06

Similar Documents

Publication Publication Date Title
EP0569797A3 (zh)
DK0599160T3 (zh)
DK0553681T3 (zh)
DK0581129T3 (zh)
DK0571874T3 (zh)
DK0574276T3 (zh)
DK0571172T3 (zh)
DK0576097T3 (zh)
BR9202713C1 (zh)
DK0590732T3 (zh)
DE9209779U1 (zh)
AU631518B2 (zh)
AU2840792A (zh)
CN3011936S (zh)
AU1729392A (zh)
AU1809592A (zh)
AU1844392A (zh)
AU1849392A (zh)
AU1933792A (zh)
AU1935292A (zh)
AU2130892A (zh)
AU2527392A (zh)
AU1707592A (zh)
AU1622092A (zh)
AU633796B1 (zh)